Mumbai-based healthcare startup Icanheal raises Rs 15 crore in a seed round

Mumbai-based healthcare startup Icanheal has raised Rs 15 crore in a seed funding round from IvyCap Ventures.

Through its wholly-owned subsidiary Rx Consultants Pvt Ltd (RXCS), Icanheal focuses on improving healthcare affordability and patient navigation, particularly for those facing critical care diseases like cancer.

The startup offers customized healthcare financing solutions to bridge the gap for patients struggling to afford timely and effective treatments.

Enhancing Icanheal's platform

The startup plans to use the raised capital to enhance its platform, enabling it to cater to millions of patients.

By offering tailored financing options, Icanheal aims to democratize access to advanced medical interventions, including medicines, devices, and hospital surgeries. These solutions are designed to increase accessibility and improve adherence to treatments, thereby enhancing overall health outcomes.

"Icanheal's unique approach to improving healthcare affordability through customized financing solutions resonates deeply with our mission. By democratizing access to advanced medical treatments and enhancing patient adherence, Icanheal is poised to make a significant impact in the healthcare sector," said Vikram Gupta, Founder and Managing Partner of IvyCap Ventures.

Leadership comments

"We are grateful to Vikram and IvyCap Ventures for their trust and investment in our vision. Healthcare in India is evolving rapidly, and our platform aims to make advanced treatments more affordable and accessible to all patients. This funding will enable us to scale our operations and further our mission of improving healthcare outcomes nationwide," Girish Poddar and Amit Backliwal, co-founders of Icanheal said.

Vikram Gupta will join the Icanheal board on behalf of IvyCap Ventures, bringing his expertise and commitment to supporting innovations that address critical healthcare challenges in India.